INM-901 significantly reduced pro-inflammatory cytokines associated with Alzheimer'sStatistically significant reduction in ...

Another challenge is the stability of mRNA molecules. Efforts are being made to engineer mRNA with enhanced stability and reduced immunogenicity to improve its therapeutic efficacy and safety profile.

CAMBRIDGE, MA / ACCESS Newswire / January 17, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced ongoing support from the U.S. Department of Health and Human Services (HHS) to accelerate the ...

This tail is the limiting step for mRNA degradation. “We wondered, why can’t we make multiple tails?” Wang said. “That way, if we lose one, there can be many others.” Wang and her team first ...

A breakthrough in Russia promises to redefine cancer treatment, with the country announcing its first mRNA cancer vaccine.

A global international trial of an mRNA vaccine against norovirus is getting underway with the aim of reducing the health burden caused by the infamous “winter vomiting” bug. The trial has ...

Short positions announced for FTAI, revenue updates for MRNA, and price forecasts changed for GME, SNAP, RKLB, NTRA, LLY, ICLR, BNTX, NVO, and BMRN. The CDC issued a health advisory Thursday ...

Merck and Moderna released “extremely impressive” positive data from a mid-stage trial of the world’s first personalized mRNA cancer vaccine for melanoma, the deadliest form of skin cancer ...